Human in Motion Robotics Unveils the Revolutionary XoMotion™ Exoskeleton After Canadian Approval
Human in Motion Robotics is excited to announce that XoMotion™, the world’s most advanced medical exoskeleton, has gained regulatory approval to be marketed and sold in Canada. This revolutionary device is poised to transform ambulatory training in rehabilitation facilities by offering exceptional support to patients with spinal cord injuries, stroke, and other neurological conditions. Featuring groundbreaking self-balancing and hands-free technology, XoMotion™ will set a new standard in rehabilitation.
Redefining Rehabilitation Technology
XoMotion™ distinguishes itself with its ability to simulate natural human movements, making it intuitive and user-friendly for both patients and therapists. This cutting-edge exoskeleton leverages advanced humanoid robotics to reduce the physical strain on therapists, as it assists in lifting, mobilizing, and training patients. By enhancing safety and efficiency, XoMotion™ significantly improves rehabilitation programs.
Highlights of XoMotion™ include:
– Self-Balancing: Ensures stability and safety throughout use.
– Hands-Free: Facilitates natural movement and allows for normal upper body function.
– Omnidirectional: Capable of performing a diverse range of complex ambulatory tasks.
– Versatile: Suitable for patients with various conditions from acute to chronic stages, including SCI and stroke.
– Safe: Reduces the physical burden on therapists, allowing them to focus more on patient care.
Global Growth and Accessibility
Receiving the Medical Devices Establishment License in Canada is a monumental step forward for Human in Motion Robotics. This makes XoMotion™ the first self-balancing exoskeleton system available in the Canadian market. The company aims to extend its reach by seeking regulatory approvals across other key regions, including the US, Asia, and the EU.
“We’re setting a new benchmark in rehabilitation technology with XoMotion™,” said Siamak Arzanpour, CEO of Human in Motion Robotics. “Our exoskeleton not only empowers patients with functional and natural movement but also alleviates the physical demands on therapists. The approval from Health Canada is an essential milestone towards our goal of global accessibility, and we are committed to advancing this progress in other major markets.”
Availability
XoMotion™ is now available for rehabilitation and research facilities in Canada and for scientific investigators worldwide who are engaged in rehabilitation or robotics research. For more information or to request a demonstration, please visit Human in Motion’s website or contact the company directly.
About Human in Motion Robotics
Human in Motion Robotics is at the forefront of robotic mobility and humanoid technology, focused on developing innovative solutions that improve patient outcomes and support healthcare professionals. The company’s mission is to revolutionize personal mobility through state-of-the-art technology and a customer-focused approach.
For media inquiries, please contact:
Phil Astrachan
VP of Marketing
[Contact Information]
415-310-7466
Human in Motion Robotics Inc.
